Episode 57: Limited predictive utility of spinal cord stimulation trial pain metrics for post-implant outcomes
In this episode of RAPM Focus, Editor Ryan D’Souza, MD, discusses with authors David Provenzano, MD, and Alexander Keith, MD candidate, a fundamental question in spinal cord stimulation: how well does a successful spinal stimulator trial actually predict success after implantation? The conversation follows the August 2026 publication of their original research paper, “Limited predictive utility of spinal cord stimulation trial pain metrics for post-implant outcomes.” Dr. Provenzano is the president of Pain Diagnostics & Interventional Care. He is an internationally recognized leader in the field of pain medicine, and is the Immediate Past President of ASRA Pain Medicine. He holds multiple academic appointments at the University of Pittsburgh Medical Center and Duquesne University. Alexander Keith is a fourth-year medical student at the Northeast Ohio Medical University, pursuing a career in orthopedic surgery. His research interests include orthopedic trauma, pain medicine, and, neuromodulation, with a focus on clinical outcomes and improving pain patient care. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Podcast and music produced by Dan Langa. Find us on X @RAPMOnline, LinkedIn @Regional Anesthesia & Pain Medicine, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.